LIGAND PHARMACEUTICALS INC - 30 Sep 2022 Form 3 Insider Report for OmniAb, Inc.

Role: 10%+ Owner
Signature: /s/ Charles S. Berkman, Senior Vice President, General Counsel and Secretary of Ligand Pharmaceuticals Incorporated
Issuer symbol: N/A
Transactions as of: 30 Sep 2022
Net transactions value: $0
Form type: 3
Filing time: 30 Sep 2022, 19:59:03 UTC
Next filing: 03 Nov 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding		Common Stock						1,000	30 Sep 2022	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.